Colorectal cancer is the second most common cause of cancer deaths in the US. A better understanding of its pathogenesis might lead to earlier diagnosis and/or prevention of this disease. Aberrant crypt foci (ACF) are the earliest identified neoplastic lesions in the colon. They are identified microscopically in whole-mount specimens of colon and recently have been identified in vivo in humans by endoscopy. Our hypothesis is that at least some of these benign neoplasms progress to malignant colon cancer. If we knew what alternation(s) in a normal colonic epithelial cell cause it to become neoplastic and/or what characteristics in ACF promote these benign neoplasms to become malignant, a greater number of colon cancers might be prevented. The APC/beta catenin pathway appears to play a key role in colon tumorigenesis. Its role in the formation and/or promotion of ACF will be examined by looking at the expression of several proteins in the APC/beta catenin pathway in serial histological sections of ACF that have been characterized for dysplasia. In adjacent sections, the expression of cyclooxygenase-2 will be evaluated. Chromosomal instability (CIN) appears to be a major player in 85 percent of sporadic colon cancers. Comparative genomic hybridization (CGH) will be used to evaluate if chromosomal instability is evident in ACF and what the earliest changes are. Fluorescence in situ hybridization (FISH) will be used on ACF to confirm the findings of CGF, to extend those findings to a larger number of ACF, and/or to detect gains or losses of chromosomal segments that have been reported in adenomas. Chromosomal instability also will be evaluated in ACF by looking for loss of heterozygosity (LOH) at several chromosomal locations. Primers for several microsatellite markers will be used with the polymerase chain reaction (PCR) to amplified DNA from microdissected ACF. Correlation of these multiple studies on the same ACF should provide new insights into the role of ACF in colon tumorigenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA066725-10
Application #
6831693
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Wagner, Paul D
Project Start
1996-02-09
Project End
2006-11-30
Budget Start
2004-12-01
Budget End
2006-11-30
Support Year
10
Fiscal Year
2005
Total Cost
$267,750
Indirect Cost
Name
Case Western Reserve University
Department
Pathology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Kearney, Kathleen E; Pretlow, Thomas G; Pretlow, Theresa P (2009) Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention. Int J Cancer 125:249-52
Luo, Liping; Shen, Gong-Qing; Stiffler, Karen A et al. (2006) Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer. Carcinogenesis 27:1153-9
Chen, Wei-Dong; Han, Z James; Skoletsky, Joel et al. (2005) Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 97:1124-32
Pretlow, Theresa P; Pretlow, Thomas G (2005) Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta 1756:83-96
Luo, Liping; Chen, Wei-dong; Pretlow, Theresa P (2005) CpG island methylation in aberrant crypt foci and cancers from the same patients. Int J Cancer 115:747-51
Pretlow, Theresa P; Edelmann, Winfried; Kucherlapati, Raju et al. (2003) Spontaneous aberrant crypt foci in Apc1638N mice with a mutant Apc allele. Am J Pathol 163:1757-63
Luo, Liping; Li, Biaoru; Pretlow, Theresa P (2003) DNA alterations in human aberrant crypt foci and colon cancers by random primed polymerase chain reaction. Cancer Res 63:6166-9
Li, Hui; Myeroff, Lois; Smiraglia, Dominic et al. (2003) SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc Natl Acad Sci U S A 100:8412-7
Hardy, R G; Tselepis, C; Hoyland, J et al. (2002) Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon. Gut 50:513-9
Hao, X P; Pretlow, T G; Rao, J S et al. (2001) Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients. Cancer Res 61:419-22

Showing the most recent 10 out of 17 publications